scholarly journals Repeated changes of the molecular subtype in gastric metastasis from breast cancer: A case report

2016 ◽  
Vol 4 (5) ◽  
pp. 695-698 ◽  
Author(s):  
JUN NAKAMURA ◽  
KEIICHIRO OKUYAMA ◽  
HIROFUMI SATO ◽  
YUKIE YODA ◽  
KEITA KAI ◽  
...  
2012 ◽  
Vol 23 (6) ◽  
pp. 808-809 ◽  
Author(s):  
Naciye Cigdem ARSLAN ◽  
Koray ATILLA ◽  
Seymen BORA ◽  
Mehtat UNLU

1999 ◽  
Vol 60 (10) ◽  
pp. 2647-2651
Author(s):  
Taro OSHIKIRI ◽  
Fumitaka NAKAMURA ◽  
Yoshiaki NARITA ◽  
Mitsuru DOHKE ◽  
Nobuichi KASHIMURA ◽  
...  

2017 ◽  
Vol 8 (6) ◽  
pp. 200-202
Author(s):  
Christos Konstantinidis ◽  
Ioannis Stefanidis

Author(s):  
Tiago Magalhães Cardoso ◽  
Douglas Dallas Muniz Dias ◽  
Joanna Cyrene Duarte Chagas Cohen ◽  
Juan Eduardo Rios Rodriguez

Cureus ◽  
2020 ◽  
Author(s):  
Alejandro Aranda-Gutierrez ◽  
Analy Gomez-Picos ◽  
Ana S Ferrigno ◽  
Mariana Moncada-Madrazo ◽  
Hector Diaz-Perez

2016 ◽  
Vol 59 (1) ◽  
pp. 18-21 ◽  
Author(s):  
David Buka ◽  
Josef Dvořák ◽  
Igor Richter ◽  
Nikolov Dimitar Hadzi ◽  
Jiří Cyrany

Background: Occurrence of gastric metastasis as the first symptom of breast carcinoma with a long period of latency before presentation of the primary breast carcinoma is rare. Case Report: A patient with gastric metastasis as the first symptom of lobular breast carcinoma, treated by neoadjuvant preoperative chemoradiotherapy and total gastrectomy, with complete local control. Fourteen months after presentation of the gastric metastasis a primary lobular breast carcinoma was discovered, treated by radiotherapy, chemotherapy and hormonal treatment with complete local response. Twenty-three months after diagnosis of breast cancer multiple colorectal metastases from the breast cancer occurred, which were treated by chemotherapy and hormonal treatment. Eighty-six months after diagnosis of gastric metastasis the patient died due to progression of cancer. Conclusions: Metastases to gastrointestinal or gynaecological tracts are more likely in invasive lobular carcinoma than invasive ductal cancer. The pathologist should determine whether or not they check estrogen and progesterone receptor status not simply by signet ring cell morphology but also by consideration of clinic-pathological correlation of the patient, such as the presence of a past history of breast cancer, or the colorectal localization of poorly differentiated carcinoma, which may occur less frequently than in the stomach.


2017 ◽  
Vol 9 (3) ◽  
pp. 318-322
Author(s):  
Kirti Bushan ◽  
Praveen Kammar ◽  
Chandraveer Singh ◽  
Suresh Advani ◽  
Praveen Mahajan

1994 ◽  
Vol 31 (4) ◽  
pp. 759
Author(s):  
Kyung Joo Park ◽  
Chun Hwan Han ◽  
Jeong Geun Yi ◽  
Joo Hyuk Lee

Sign in / Sign up

Export Citation Format

Share Document